Structured follow-up for childhood blood cancer survivors
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at a structured follow-up program to help children who survived blood cancers stay healthy and catch any late side effects early. If your child has finished treatment for a blood cancer and is between 1 and 21, this could help them get ongoing care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child was diagnosed with a blood cancer (like leukemia or lymphoma) as a child.
- Your child finished their main treatment at least 12 months ago.
- Your child is between 1 and 21 years old.
- Your child can attend follow-up visits and provide the needed information.
- Your child does not have severe organ failure or other major health conditions that would make follow-up difficult.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at the medical records of children and young adults diagnosed with cancer in the last 15 years. It helps researchers understand more about cancer in young people.
This study follows children and teens with newly diagnosed certain leukemia (ALL) and certain favorable brain tumors to learn best care and outcomes. It may help your team compare standard treatments and monitor health over time.
This trial tracks the long-term health of people who took part in previous Children's Oncology Group studies. It helps doctors understand the lasting effects of cancer treatment and improve care for survivors.
This study enrolls adults with certain blood cancers to better understand diagnosis, treatment choices, and outcomes. You may also be asked to provide or have tissue/blood samples saved so researchers can study what’s going on in the disease.
This study follows people who survived certain childhood cancers to learn what long-term health effects may happen after treatment. It also compares survivors with siblings to help researchers understand differences that may be related to cancer or treatment.
This study looks at the long-term health effects of hematopoietic (blood-forming) stem cell transplants. It may help doctors better understand and manage late side effects for children and teens after transplant.
Hear when a new Acute Lymphoblastic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.